Cite
HARVARD Citation
Luminari, S. et al. (n.d.). POD24 AND CR30 ARE PROMISING SURROGATE ENDPOINTS FOR ASSESSING THE OUTCOME OF PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA ENROLLED IN THE FOLL05 TRIAL BY FIL.. Hematological oncology. pp. 228-229. [Online].